LTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patches

Contributed by: PR Newswire

Tags

LTS-Lohmann-Therapie-

More Like This

LTS receives $4.3 Million grant for the development of contraceptive Microneedle Array Patches

First product based on LTS Sorrel™ wearable drug delivery platform launched in the US

PartitionBio™ awarded grant to exploit its novel biologics shuttle platform for therapeutic nucleic acids delivery

ReNAgade Therapeutics to Present Preclinical Data Demonstrating Potent Extra-Hepatic Delivery of mRNA Using Proprietary Lipid Nanoparticles at 11th International mRNA Health Conference

TriLink BioTechnologies® Cuts Ribbon on New San Diego Facility for Late Phase mRNA Drug Substance Production (Photo: TriLink BioTechnologies®)

TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production

PR Newswire associated0

Turn Biotechnologies First to Deliver mRNA into the Dermis Using Proprietary LNPs, With No Distribution to Other Organs

Release Therapeutics Secures CHF 3.3 Million in Seed Funding

PR Newswire associated0

WestGene leads the way in mRNA innovation at the 4th mRNA Therapeutics Summit